EX-10.1
from 8-K
3 pages
To the Holders (The “Holders”) of the Secured Promissory Notes, Dated January 15, 2009 (The “Notes”), by Oncovista Innovative Therapies, Inc., a Nevada Corporation (“Oit”), and Oncovista, Inc., a Delaware Corporation (“Oncovista”, And, Together With Oit, the “Company”), Due on January 15, 2010 and the Holders of the Warrants for the Purchase of Securities, Dated January 15, 2009 (The “Warrants”), Issued by Oit I. Notes Amendments. A. Except as Otherwise Expressly Provided Herein, the Notes Shall Continue in Full Force and Effect; B. the Definition of “Maturity Date” Set Forth in Section 1 of the Notes Is Hereby Amended to Be and Read in Its Entirety as Follows: “Maturity Date Means the Earlier of (I) July 15, 2010, (II) the Date Upon Which the Company Consummates a Qualified Financing and (III) the Acceleration of the Maturity of the Note in Accordance With Section 2(b).” C. the Definition of “Qualified Financing” Set Forth in Section 1 of the Notes Is Hereby Amended to Be and Read in Its Entirety as Follows: “Qualified Financing Means One or More Financings, Whether in the Form of Equity Securities, Indebtedness, Derivative Securities, or Otherwise, the Aggregate Gross Proceeds of Which Equal or Exceed $3,000,000. D. Section 2(b) of the Notes Is Hereby Amended to Be and Read in Its Entirety as Follows
12/34/56
